4889 Renascience Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4889

TSE Growth

Renascience Inc.

2,029

JPY

-7

(-0.34%)

Mar 13, 3:30 pm JST

12.72

USD

Mar 13, 2:30 am EDT

Result

PTS

outside of trading hours

2,011

Mar 13, 11:57 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	139	-210	-241	-254	-22.3	0	May 12, 2022	J-GAAP
Mar, 2023	100	-333	-333	-335	-26.4	0	May 11, 2023	J-GAAP
Mar, 2024	194	-252	-251	-258	-20.3	0	May 9, 2024	J-GAAP
Mar, 2025	132	-178	-178	113	8.9	0	May 14, 2025	J-GAAP
Mar, 2026 Guidance	95	-425	-386	-387	-28.6	0	Mar 11, 2026	J-GAAP
YoY	-28.0%	-138.8%	-116.9%	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2022	Sep 24, 2021	122	-395	-399	-400	0*	J-GAAP
	Feb 14, 2022	139	-263	-294	-294	0*	J-GAAP
Results	May 12, 2022	139	-210	-241	-254	0*	J-GAAP
Mar, 2023	May 12, 2022	Available in future release
	Mar 9, 2023
Results	May 11, 2023
Mar, 2024	May 11, 2023
Results	May 9, 2024
Mar, 2025	May 9, 2024
	Jul 3, 2024
	Dec 6, 2024
Results	May 14, 2025
Mar, 2026	May 14, 2025	113	-397	-360	-362	0	J-GAAP
	Nov 12, 2025	133	-380	-343	-345	0	J-GAAP
	Mar 11, 2026	95	-425	-386	-387	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2017	69	－	Available in future release
Mar, 2018	9	-87.0
Mar, 2019	ー	-100.0
Mar, 2020	72	－
Mar, 2021	209	+190.3
Mar, 2022	139	-33.5
Mar, 2023	100	-28.1
Mar, 2024	194	+94.0
Mar, 2025	132	-32.0
Mar, 2026 Guidance	95	-28.0	-425	-138.8	-386	-116.9	-28.6	－

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	194	-252	-130	-14.87	-11.83	0.09	-20.3
Mar, 2025	132	-178	-135	6.79	5.71	0.07	8.9
Mar, 2026 Guidance	95	-425	-447	-16.04	-15.12	0.04	-28.6

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	209	-86	-1	113	8.9
Fiscal Year	Mar, 2021	Mar, 2021	Mar, 2017	Mar, 2025	Mar, 2025

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	80	-181	-181	-182	-14.4	0	May 11, 2023	J-GAAP
Oct - Mar, 2023	74	-158	-157	-163	-12.8	0	May 9, 2024	J-GAAP
Oct - Mar, 2024	77	-88	-86	185	14.6	0	May 14, 2025	J-GAAP
Oct - Mar, 2025 Guidance	85	-237	-235	-236	-17.5	0	Mar 11, 2026	J-GAAP
YoY	+10.4%	-169.3%	-173.3%	－	－

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	-333	-284	-284	0	110	1,831	80.52	J-GAAP
Mar, 2024	-252	-231	-230	-1	46	1,646	78.83	J-GAAP
Mar, 2025	-178	206	-176	382	-52	1,799	96.15	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2023	120	-221	-221	-222	-17.5	ー	Feb 8, 2024	J-GAAP
Apr - Dec, 2024	65	-139	-140	154	12.1	ー	Feb 13, 2025	J-GAAP
Apr - Dec, 2025	40	-255	-217	-218	-17.2	ー	Feb 13, 2026	J-GAAP
YoY	-38.5%	-83.5%	-55.0%	－	－

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	74	-31	-30	-36	-2.8	-41.9	May 9, 2024	J-GAAP
Apr - Jun, 2024	40	-36	-36	-16	-1.3	-90.0	Aug 8, 2024	J-GAAP
Jul - Sep, 2024	15	-54	-56	-56	-4.5	-360.0	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	10	-49	-48	226	17.8	-490.0	Feb 13, 2025	J-GAAP
Jan - Mar, 2025	67	-39	-38	-41	-3.2	-58.2	May 14, 2025	J-GAAP
Apr - Jun, 2025	10	-102	-66	-66	-5.3	-1,020.0	Aug 13, 2025	J-GAAP
Jul - Sep, 2025	0	-86	-85	-85	-6.7	-Inf	Nov 12, 2025	J-GAAP
Oct - Dec, 2025	30	-67	-66	-67	-5.3	-223.3	Feb 13, 2026	J-GAAP
YoY	+200.0%	-36.7%	-37.5%	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Apr - Jun, 2021	31	－	Available in future release
Jul - Sep, 2021	0	－
Oct - Dec, 2021	35	－
Jan - Mar, 2022	73	－
Apr - Jun, 2022	20	-35.5
Jul - Sep, 2022	0	－
Oct - Dec, 2022	10	-71.4
Jan - Mar, 2023	70	-4.1
Apr - Jun, 2023	93	+365.0
Jul - Sep, 2023	27	－
Oct - Dec, 2023	0	-100.0
Jan - Mar, 2024	74	+5.7
Apr - Jun, 2024	40	-57.0
Jul - Sep, 2024	15	-44.4
Oct - Dec, 2024	10	－
Jan - Mar, 2025	67	-9.5
Apr - Jun, 2025	10	-75.0
Jul - Sep, 2025	0	-100.0
Oct - Dec, 2025	30	+200.0	-67	-36.7	-66	-37.5	-5.3	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	93	2	2	226	17.8
Fiscal Year	Jun, 2023	Jun, 2023	Jun, 2023	Dec, 2024	Dec, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	146.72	82.0	2,274	1,865	-690	0.17	May 11, 2023	J-GAAP
Mar, 2024	126.40	76.9	2,088	1,606	-948	0.22	May 9, 2024	J-GAAP
Mar, 2025	135.32	91.9	1,871	1,720	-835	ー	May 14, 2025	J-GAAP
Apr - Dec, 2025	ー	94.3	2,560	2,413	-1,053	ー	Feb 13, 2026	J-GAAP

Renascience Inc.(4889) Financial Results